Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:28 March,2020
Covid-19 race for cure: Drugs on trial
ET: Drug companies and research organisations seeking a Covid-19 cure are turning to old molecules that are either out of production or those on which development work stopped due to lack of commercial viability. On Friday, India said it will join the global solidarity drug trial launched by the World Health Organisation (WHO), which means its patients will participate in trials for more than 20 or so molecules that may offer a way forward, reports DIVYA RAJAGOPAL in this week’s update on the state of Covid-19 vaccine and drug development....read more
Corona Medtalks - Telemedicine Guidelines, More Tests (For attention of Doctors)
Should India adopt a mass testing policy similar to South Korea?
CMAAO IMA HCFI Corona Myth Buster 19 (For attention of Doctors)
Maximum cases are in China: No, the cases in USA are now over 85377
"I cry for the ones who passed away. I cry because we intubated 5 patients within 10 min and I am terrified. I cry for my co workers, because we know it will get worse and I already feel like that is impossible and we are already at our breaking point, I cry for the parents, children, siblings, spouses who cannot be with their loved ones who may be dying but cant have visitors because there is no visiting allowed," stated the nurse. [NBC Palm Springs] ....read more
Why do people suffer?
As per Garud Puran and Hindu mythology, one of the reasons for suffering is the debts of your past birth. Your purpose of life is to face sufferings to pay these debts. The second reason is your present deeds till today starting from birth. If your sum total of bad deeds is more than good deeds, they get added to your previous birth’s debts....read more
Health Sutras By Dr K K Aggarwal
Always have faith in your doctor.
Healthcare News Monitor
Mint- Srishti Choudhary
With a long road ahead for vaccines and drugs, scientists are now exploring age-old technique of passive antibody therapy as potential treatment for COVID-19, which has infected over 5 lakh people across the world and killed at least 24,000. Antibodies are protein molecules released by the body when a foreign substance (like for instance, virus) enters the system. These molecules bind to the foreign substance and neutralize it. Simply put, they are the weapon used by the immune system to fight new infections. In case of COVID-19, over 1.22 lakh people, including a large young population, infected with the disease have recovered globally. Now, some molecular laboratories and diagnostic companies in countries worst hit by the pandemic -- China and US-- are racing to develop effective tests which can detect and assess these antibodies in the blood of patients who have recovered from the illness and also analyse if the antibody laden plasma of these recovered persons can be infused in patients at early stage of the disease.
Microbiz India- Jeetendra Kumar
In what could be uplifting news for Indian medication producers, the import of Active pharmaceutical ingredients (APIs) and other crude materials from China has continued. Following the flare-up of Covid-19 in China, fare of crude materials from that nation to India was upset as most producers stopped tasks. “The import of crude materials from China initiated around 10 days prior and we are currently accepting them from all regions aside from one,” R Uday Bhaskar, Director-General, Pharmaceutical Export Promotion Council (Pharmexcil), told media on Wednesday. India imports about $2.5-billion worth of APIs from China, as indicated by Pharmexcil information. The business had before communicated worry over the interruption of imports from China and said the current stock would be sufficient to run creation for as long as a quarter of a year. A Pharmexcil official said that the resumption of imports was a decent improvement. Chinese makers have likewise passed on their preparation to supply to India individual security hardware that will be pivotal in battling the Covid-19 disease. “We have been drawn closer on this by China just yesterday and are chipping away at it,” he said. Be that as it may, the condition of inner coordinations and the failure to move shipments are a worry. Both for import of crude materials from China, and pharma sends out, the lockdown has been a test, with dropping everything being equal, suspension of tasks at ports, and trucks goes romping.
Reuters - Alexandra Ulmer, Zeba Siddiqui
As the coronavirus spread across Asia in February, Indian manufacturers of personal protective equipment contacted the health ministry urging the government to stock up. They got no response, according to Sanjeev Relhan and Rajiv Nath, the heads of two health-sector manufacturing associations. They and other manufacturers now say such poor communication led to the squandering of precious time in the race to protect health workers fighting the coronavirus. The health ministry did not respond to multiple requests for comment. India has reported 724 cases of the coronavirus including 17 deaths and Prime Minister Narendra Modi has locked down the entire country for three weeks in the world’s most ambitious bid to control the epidemic. Rehlan said they met textile ministry officials on March 16, only to learn equipment specifications had already been set. Then, on Saturday, Nath said he was informed by a health ministry official that a tender for the equipment had been issued 16 days earlier, but many manufacturers had not been aware of it. “We sent daily emails from March 13 until March 21. If the tender was available why didn’t they share it?” said Relhan, chair of the Preventive Wear Manufacturer Association of India. The government banned exports of personal protective equipment on Jan. 31 to avoid shortages but other manufacturers of the equipment rued what they saw as a waste of time in getting ready to face the virus. “If we were preparing ourselves from February everyone would have been ready,” said Smita Shah, managing director of Mediklin Healthcare.
They have been hailed as India's coronavirus "heroes", but doctors, nurses, delivery drivers and other frontline workers have been attacked and in some cases evicted from their homes by panicked residents. Some e-commerce giants have even halted deliveries partly due to the harassment of staff, while Prime Minister Narendra Modi said abuse of hospital workers had become a "huge issue". Reports of attacks and abuse have come from across India, increasing with the imposition this week of a 21-day nationwide lockdown. In at least one case, police were accused of beating a delivery driver carrying medicines. Sanjibani Panigrahi, a doctor based in Surat, described how she was accosted as she returned home from a long day at a hospital that is treating COVID-19 patients. She said neighbours blocked her at the entrance to her apartment building and threatened "consequences" if she continued to work. "These are the same people who have happily interacted with me (in the past). Whenever they've faced a problem, I've helped them out," the 36-year-old told AFP. "There is a sense of fear among people. I do understand. But it's like I suddenly became an untouchable."